Cassava Sciences, Inc.
SAVA
$2.18
$0.041.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -66.34% | -15.81% | 9.60% | -25.11% | 3,777.04% |
| Gross Profit | 66.34% | 15.81% | -9.60% | 25.11% | -3,777.04% |
| SG&A Expenses | -82.74% | 18.19% | -123.83% | 228.51% | 1,265.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -79.03% | -5.88% | -13.67% | 13.79% | 133.53% |
| Operating Income | 79.03% | 5.88% | 13.67% | -13.79% | -133.53% |
| Income Before Tax | -818.51% | -193.45% | -31.92% | -8.94% | 123.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -818.51% | -193.45% | -31.92% | -8.94% | 123.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -818.51% | -193.45% | -31.92% | -8.94% | 123.34% |
| EBIT | 79.03% | 5.88% | 13.67% | -13.79% | -133.53% |
| EBITDA | 79.26% | 5.56% | 13.46% | -14.47% | -135.68% |
| EPS Basic | -787.31% | -183.26% | -15.71% | 4.63% | 121.11% |
| Normalized Basic EPS | -3,583.33% | -182.46% | 25.42% | 0.86% | 101.22% |
| EPS Diluted | -807.69% | -14.07% | -14.60% | 4.63% | 120.60% |
| Normalized Diluted EPS | -3,583.33% | -184.57% | 25.42% | 0.86% | 101.22% |
| Average Basic Shares Outstanding | 4.56% | 12.23% | 14.01% | 14.22% | 10.55% |
| Average Diluted Shares Outstanding | 4.56% | 9.43% | 14.01% | 14.22% | 10.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |